Transwell assay results demonstrated that under both non-Matrigel (migration) and Matrigel-coated (invasion) conditions, ZMYND8-overexpressing breast cancer cells exhibited significantly enhanced migratory and invasive capabilities (Fig. 3C). This evidence concerns the gene ZMYND8 and breast carcinoma.